Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 430-436

  Tewari, Ashutosh ^a   Narayan, Perinchery ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Artificial intelligence; Cost effective analysis; Neural networks (computer); Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; ARTIFICIAL NEURAL NETWORK; CANCER LOCALIZATION; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL ANALYSIS;

EID: 0032324086     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62916-1     Document Type: Article

References (72)

1. Parker, S. L., Tong, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1997. CA, 47: 5, 1997.
2. Oesterling, J. E.: Using prostate-specific antigen to eliminate unnecessary diagnostic tests: significant worldwide economic implications. Urology, 46: 26, 1995.
3. Mettlin, C. J., Murphy, G. P., McGinnis, L. S. and Menck, H. R.: The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer, 76: 1104, 1995.
4. Mettlin, C. J., Murphy, G. P., Ho, R. and Menck, H. R.: The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer, 77: 2162, 1996.
5. Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P. and Barrett, D. M.: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J. Urol., 152: 1850, 1994.
6. Murphy, G. P.: Prostate cancer: here and now (editorial). CA, 45: 1995.
7. Epstein, J. I., Partin, A. W., Sauvageot, J. and Walsh, P. C.: Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Amer. J. Surg. Path., 20: 286, 1996.
8. Linzer, D. G., Stock, R. G., Stone, N. N., Ratnow, R., Ianuzzi, C. and Unger, P.: Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer. Urology, 48: 757, 1996.
9. Soh, S., Kattan, M. W., Berkman, S., Wheeler, T. M. and Scardino, P. T.: Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J. Urol., 157: 2212, 1997.
10. Lerner, S. E., Blute, M. L. and Zincke, H.: Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Sem. Urol. Oncol., 14: 12, discussion 21, 1996.
11. Ohori, M., Wheeler, T. M., Dunn, J. K., Stamey, T. A. and Scardino, P. T.: The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J. Urol., 152: 1714, 1994.
12. Mettlin, C., Murphy, G. P., Lee, F., Littrup, P. J., Chesley, A., Babaian, R., Badalament, R., Kane, R. A. and Mostofi, F. K.: Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cancer, 72: 1701, 1993.
13. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
14. Epstein, J. I., Carmichael, M. J., Pizov, G. and Walsh, P. C.: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J. Urol., 150: 135, 1993.
15. Krongrad, A., Lai, H. and Lai, S.: Survival after radical prostatectomy. J.A.M.A., 278: 44, 1997.
16. Epstein, J. I.: Incidence and significance of positive margins in radical prostatectomy specimens. Urol. Clin. N. Amer., 23: 651, 1996.
17. Menon, M., Parulkar, B. G. and Baker, S.: Should we treat localized prostate cancer? An opinion. Urology, 46: 607, 1995.
18. Menon, M.: Editorial: predicting biological aggressiveness in prostate cancer - desperately seeking a marker. J. Urol., 157: 228, 1997.
19. Oesterling, J. E.: Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications. Urol. Clin. N. Amer., 20: 705, 1993.
20. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
21. Partin, A. W., Kattan, M. W., Subong, E. N., Walsh, P. C., Wojno, K. J., Oesterling, J. E., Scardino, P. T. and Pearson, J. D.: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J.A.M.A., 277: 1445, 1997.
22. Narayan, P., Gajendran, V., Taylor, S. P., Tewari, A., Presti, J. C., Jr., Leidich, R., Lo, R., Palmer, K., Shinohara, K. and Spaulding, J. T.: The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology, 46: 205, 1995.
23. Bostwick, D. G., Qian, J., Bergstralh, E., Dundore, P., Dugan, J., Myers, R. P. and Oesterling, J. E.: Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J. Urol., 155: 1361, 1996.
24. Badalament, R. A., Miller, M. C., Peller, P. A., Young, D. C., Bahn, D. K., Kochie, P., O'Dowd, G. J. and Veltri, R. W.: An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. J. Urol., 156: 1375, 1996.
25. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Schnall, M., Tomaszewski, J. E. and Wein, A.: Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure. Urology, 49: 23, 1997.
26. Kattan, M. W., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer, 79: 528, 1997.
27. Tewari, A. and Narayan, P.: Cost effective staging of prostate cancer using genetic adaptive neural networks. Presented at annual meeting of Southeastern Section of American Urological Association, Naples, Florida, March 8-11, 1997.
28. Tewari, A., Mager, J., Kamerer, A., Shukla, A. and Narayan, P.: Genetic adaptive probabilistic neural network models in prediction of pathological stage in management of localized prostate cancer: a pilot study. J. Urol., part 2, 157: 293, abstract 1142, 1997.
29. Walsh, P. C. and Partin, A. W.: Treatment of early stage prostate cancer: radical prostatectomy. Important Adv. Oncol., p. 211, 1994.
30. Walsh, P. C.: Editorial: the status of radical prostatectomy in the United States in 1993: where do we go from here? J. Urol., 152: 1816, 1994.
31. Walsh, P. C.: Re: Potency-sparing radical retropubic prostatectomy: a simplified anatomical approach. J. Urol., 155: 294, 1996.
32. Bergeron, B. P., Shiffman, R. S. and Rouse, R. L.: Data qualification: logic analysis applied toward neural network training. Comput. Biol. Med., 24: 157, 1994.
33. Borisyuk, G. N., Borisyuk, R. M., Khibnik, A. I. and Roose, D.: Dynamics and bifurcations of two coupled neural oscillators with different connection types. Bull. Math. Biol., 57: 809, 1995.
34. Burke, H. B.: Artificial neural networks for cancer research: outcome prediction. Sem. Surg. Oncol., 10: 73, 1994.
35. Dassen, W. R. and Mulleneers, R. G.: The value of artificial neural network techniques to develop diagnostic systems in cardiology. Pacing. Clin. Electrophysiol., 17: 1672, 1994.
36. Forrest, S.: Genetic algorithms: principles of natural selection applied to computation. Science, 261: 872, 1993.
37. Forsström, J. J. and Dalton, K. J.: Artificial neural networks for decision support in clinical medicine. Ann. Med., 27: 509, 1995.
38. Fu, L.: Neural Networks in Computer Intelligence and SubNeural Networks in Computer Intelligence. New York: McGraw-Hill, Inc., pp. 1-61, 1994.
39. Jakobsen, E., Kruse-Andersen, S. and Kolberg, J.: Neural network for automatic analysis of motility data. Methods. Inf. Med., 33: 157, 1994.
40. Kattan, M. W., Cowen, M. E. and Miles, B. J.: Computer modeling in urology. Urology, 47: 14, 1996.
41. Lamb, D. J. and Niederberger, C. S.: Artificial intelligence in medicine and male infertility. World J. Urol., 11: 129, 1993.
42. Tetko, I. V., Villa, A. E. and Livingstone, D. J.: Neural network studies. 2. Variable selection. J. Chem. Inf. Comput. Sci., 36: 794, 1996.
43. Takahashi, Y.: A mathematical solution to a network designing problem. J. Comput. Biol., 3: 97, 1996.
44. Wasserman, P.: Neural Computing: Theory and Practice and SubNeural Computing: Theory and Practice, New York: Van Nostrand Reinhold, pp. 1-11, 1993.
45. Hamilton, P. W., Montironi, R., Abmayr, W., Bibbo, M., Anderson, N., Thompson, D. and Bartels, P. H.: Clinical applications of Bayesian belief networks in pathology. Pathologica, 87: 237, 1995.
46. Orr, R. K.: Use of a probabilistic neural network to estimate the risk of mortality after cardiac surgery. Med. Decision Making, 17: 178, 1997.
47. Korning, P. G.: Training neural networks by means of genetic algorithms working on very long chromosomes. Int. J. Neural Systems, 6: 299, 1995.
48. Livingstone, D. J., Manallack, D. T. and Tetko, I. V.: Data modelling with neural networks: advantages and limitations. J. Comput. Aided Mol. Des., 11: 135, 1997.
49. Eisenstein, E. L. and Alemi, F.: A comparison of three techniques for rapid model development: an application in patient risk-stratification. Proc. AMIA Ann. Fall Symposium, 443, 1996.
50. Hatjimihail, A. T.: Genetic algorithms-based design and optimization of statistical quality-control procedures. Clin. Chem., 39: 1972, 1993.
51. Husbands, P., Harvey, I., Cliff, D. and Miller, G.: Artificial evolution: a new path for artificial intelligence? Brain Cognition, 34: 130, 1997.
52. Jefferson, M. F., Pendleton, N., Lucas, S. B. and Horan, M. A.: Comparison of a genetic algorithm neural network with logistic regression for predicting outcome after surgery for patients with nonsmall cell lung carcinoma. Cancer, 79: 1338, 1997.
53. Levin, M.: Use of genetic algorithms to solve biomedical problems. Methods Comput., 12: 193, 1995.
54. Saravanan, N., Fogel, D. B. and Nelson, K. M.: A comparison of methods for self-adaptation in evolutionary algorithms. Biosystems, 36: 157, 1995.
55. Brier, M. E. and Aronoff, G. R.: Application of artificial neural networks to clinical pharmacology. Int. J. Clin. Pharmacol. Ther., 34: 510, 1996.
56. Burke, H. B., Goodman, P. H., Rosen, D. B., Henson, D. E., Weinstein, J. N., Harrell, F. E., Jr., Marks, J. R., Winchester, D. P. and Bostwick, D. G.: Artificial neural networks improve the accuracy of cancer survival prediction. Cancer, 79: 857, 1996.
57. Buscema, M.: A general presentation of artificial neural networks. I. Subst. Use Misuse, 32: 97, 1997.
58. Frye, K. E., Izenberg, S. D., Williams, M. D. and Luterman, A.: Neural networks: what are they? J. Burn Care Rehab., 18: 72, 1997.
59. Minor, J. M. and Namini, H.: Analysis of clinical data using neural nets. J. Biopharm. Statistics, 6: 83, 1996.
60. Barry, M. J., Fowler, F. J., Jr., Bin, L. and Oesterling, J. E.: A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer. J. Urol., 158: 488, 1997.
61. Bostwick, D. G.: Staging prostate cancer-1997: current methods and limitations. Eur. Urol., 32: 2, 1997.
62. Murphy, W. M.: Prostate cancer. The problem of prognostic factors. Amer. J. Clin. Path., suppl., 106: S45, 1996.
63. D'Amico, A. V., Whittington, R., Schultz, D., Malkowicz, S. B., Tomaszewski, J. E. and Wein, A.: Outcome based staging for clinically localized adenocarcinoma of the prostate. J. Urol., 158: 1422, 1997.
64. Narayan, P., Fournier, G., Gajendran, V., Leidich, R., Lo, R., Wolf, J. S., Jr., Jacob, G., Nicolaisen, G., Palmer, K. and Freiha, F.: Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology, 44: 519, 1994.
65. Niederberger, C. S., Lipshultz, L. I. and Lamb, D. J.: A neural network to analyze fertility data. Fertil. Steril., 60: 324, 1993.
66. Niederberger, C. S.: Commentary on the use of neural networks in clinical urology. J. Urol., 153: 1362, 1995.
67. Niederberger, C.: Computational tools for the modern andrologist. J. Androl., 17: 462, 1996.
68. Snow, P. B., Smith, D. S. and Catalona, W. J.: Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J. Urol., 152: 1923, 1994.
69. Tewari, A., Calvanese, C., Carlson, G., Kahane, H. and Narayan, P.: An artificial intelligence based genetic adaptive neural network model to predict pathological stage of prostate cancer in patients undergoing radical prostatectomy. J. Urol., part 2, 159: 112, abstract 431, 1998.
70. Wolf, J. S., Jr., Cher, M., Dall'era, M., Presti, J. C., Jr., Hricak, H. and Carroll, P. R.: The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J. Urol., 153: 993, 1995.
71. Tempany, C. M.: MR staging of prostate cancer. How we can improve our accuracy with decisions aids and optimal techniques. Magnetic Resonance Imaging Clin. N. Amer., 4: 519, 1996.
72. Milestone, B. N. and Seidman, E. J.: Endorectal coil magnetic resonance imaging of prostate cancer. Sem. Urol., 13: 113, 1995.